Board of Directors

President
Louis James de Viel Castel
Managing Director
Quilvest Capital France
France

Vice President
Marc Sznajderman
Managing Director
HCP Real Estate Investors LLC
United States of America

Treasurer
Andrew S Rendeiro, Esq
Partner
Flamhaft, Levy, Kamins, Hirsch & Rendeiro
United States of America

Secretary
Nils E Billo, MD, MPH
Executive Director
International Union Against Tuberculosis and Lung Disease
France

Members of the Board

Peter A Baldini
CEO
New Penn Associates, LLC
United States of America

David A Caputo
President Emeritus
Pace University
United States of America

E. Jane Carter, MD
Assistant Professor of Medicine
Brown University Medical School
United States of America

José Luis Castro
Deputy Executive Director
International Union Against Tuberculosis and Lung Disease
France

Frank G. Colella J.D., LL.M, CPA
Partner
Frank G. Colella, Attorney at Law
United States of America

Prof. Donald A Enarson, MD
Senior Advisor
International Union Against Tuberculosis and Lung Disease
France

Marcos Espinal, MD
Executive Secretary
Stop TB Partnership
Switzerland

Paula I. Fujiwara, MD, MPH
Director, Department of HIV/AIDS
International Union Against Tuberculosis and Lung Disease
France

Venkatarama Rao Koppaka, MD
Senior Advisor for Public Health Systems and Program Development
Centers for Disease Control and Prevention
United States of America

Mario Raviglione, MD
Director, Stop TB Department
World Health Organization
Switzerland

Renée Ridzon, MD
Senior Program Officer, HIV, TB and Reproductive Health
Bill and Melinda Gates Foundation
United States of America

Jack Salvo
Director, Business Development and External Markets
Interchem Corporation
United States of America

Neil W. Schluger, MD
Chief, Division of Pulmonary, Allergy, and Critical Care Medicine
Columbia University Medical Center
Professor of Medicine, Epidemiology, and Environmental Health Sciences
Columbia University College of Physicians and Surgeons
United States of America